HP and adenocarcinoma: The HP positivity ratio was 63.3% in poorly differentiated adenocarcinoma cases and 68.4% in moderately differentiated adenocarcinoma cases whereas it was found to be 15.4% in moderately differentiated squamous cell carcinomas (Figure 6).